Manatt represented Vectura Group in this transaction.Vectura Group, a British pharmaceutical company focused on inhaled therapeutics, completed its $11 million pre-merger convertible note financing with EnBiotix,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
